Roy D. Baynes Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Roy D. Baynes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Roy D. Baynes. Roy D. Baynes is Director in Retrophin, Inc. ($RTRX) and in Atara Biotherapeutics, Inc. ($ATRA) and Director in Atara Biotherapeutics, Inc. ($ATRA) and Director in Natera, Inc. ($NTRA).
Latest Insider Trading Transactions of Roy D. Baynes
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRA, NTRA, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
| Aug 11 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Option Exercise | M | 24.42 | 1,300 | 31,746 | 15,230 | |
| Aug 11 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Sell | S | 53.47 | 1,300 | 69,513 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 11 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Buy | M | 24.42 | 1,300 | 31,746 | 1,300 | 0 to 1.3 K |
| Jun 17 2020 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
| Jun 17 2020 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Grant | A | 0.00 | 8,000 | 0 | 12,000 | 4 K to 12 K (+200.00 %) |
| Jun 16 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Option Exercise | A | 40.93 | 5,712 | 233,792 | 5,712 | |
| Jun 16 2020 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Option Exercise | A | 0.00 | 2,856 | 0 | 2,856 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 15.43 | 9,000 | 138,870 | 9,000 | |
| May 19 2020 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 3,000 | 0 | 14,000 | 11 K to 14 K (+27.27 %) |
| Jul 01 2019 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Option Exercise | A | 20.25 | 13,000 | 263,250 | 13,000 | |
| Jul 01 2019 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
| May 29 2019 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Option Exercise | A | 22.83 | 22,000 | 502,260 | 22,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 2,000 | 0 | 11,000 | 9 K to 11 K (+22.22 %) |
| Sep 18 2018 | NTRA | Natera, Inc. | Baynes Roy D. | Director | Option Exercise | A | 24.42 | 16,530 | 403,663 | 16,530 | |
| Sep 12 2018 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Director | Option Exercise | A | 41.05 | 16,500 | 677,325 | 16,500 | |
| May 11 2018 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 26.52 | 10,000 | 265,200 | 10,000 | |
| May 11 2018 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 2,500 | 0 | 9,000 | 6.5 K to 9 K (+38.46 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 17.44 | 10,000 | 174,400 | 10,000 | |
| May 18 2017 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 2,500 | 0 | 6,500 | 4 K to 6.5 K (+62.50 %) |
| Jul 26 2016 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 17.50 | 16,000 | 280,000 | 16,000 | |
| Jul 26 2016 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
| Jul 26 2016 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 17.50 | 16,000 | 280,000 | 16,000 | |
| Jul 26 2016 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Page: 1